EMILY BELL: Open Payments
NPI 1194201913 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 6 payments from 4 companies in 2025. Trend: 2023 $199 · 2024 $0 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
| ABBVIE INC. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: CAPLYTA, INGREZZA, VRAYLAR, Jornay PM.
Industry payments across NY — which companies pay providers there.
